Kathleen Behrens Net Worth & Insider Trades

Kathleen Behrens - Director, Igm Biosciences, Inc

As of July 5, 2022

What is Kathleen Behrens's Net Worth?

The current estimated net worth of Igm Biosciences, Inc's Director, Kathleen Behrens, is estimated to be about $12.15M . Kathleen Behrens owns about 29,806 units of Igm Biosciences, Inc common stock. In the last 3 years at Igm Biosciences, Inc, Kathleen Behrens has sold an estimated value of $0 worth.

What is Kathleen Behrens's Past Insider Trading?

Kathleen Behrens's largest purchase order was 44,444 units , worth over $4M on December 15, 2020. In total, Kathleen Behrens has made about 18 transactions over 3 years of their time at Igm Biosciences, Inc. Kathleen Behrens usually trades in April, September and July, with the busiest year in 2020. The most recent transaction was a purchase order of 61,243 units , worth over $1.4M on April 4, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Kathleen Behrens's' Mailing Address?

  • Mailing address is 6701 Kaiser Drive Fremont CA 94555 CA

Igm Biosciences, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Total
Fred Schwarzer 2020 $529,700 $4,251,990 $317,820 $5,099,510
Fred Schwarzer 2019 $428,000 $121,189 $207,911 $757,100
Bruce Keyt, Ph.D. 2020 $413,200 $2,125,995 $223,128 $2,762,323
Bruce Keyt, Ph.D. 2019 $357,000 $92,714 $151,743 $601,457
Daniel S. Chen, M.D., Ph.D. 2020 $456,250 $1,559,063 $219,000 $2,234,313
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1496323/000119312521140868/d151412ddef14a.htm

What are Igm Biosciences, Inc's Past Insider Trades?

Igm Biosciences, Inc's most recent insider trade came on May 26, 2022 by Chris Takimoto who sold 938 units worth $16.04K . In the last 3 years, insiders at Igm Biosciences, Inc have sold an estimated value of $4.9M and bought an estimated value of $237.15M worth of shares. Insider trading is most common in February, April and September, with the busiest year in 2021. The most active traders at the company are Bruce Keyt, Chief Scientific Officer,  Haldor Jakob Topsoe, Director,  and Shinyu Daniel Chen, Chief Medical Officer .

IGM Biosciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1